Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Mazor Robotics Ltd
  6. News
  7. Summary
    MZOR   IL0011068553

MAZOR ROBOTICS LTD

(MZOR)
Delayed TEL AVIV STOCK EXCHANGE  - 
- ILa   -.--%
2018Mazor Robotics : Shareholders Approve Merger Agreement With Medtronic
PU
2018Mazor Robotics : Reports Third Quarter and Nine Month 2018 Results
PU
2018Medtronic to acquire Mazor in $1.64 billion deal
RE
SummaryNewsCompanyFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Mazor Robotics Ltd : Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mazor Robotics Ltd. of Class Action Lawsuit and Upcoming Deadline - MZOR

07/30/2017 | 09:12am EST

NEW YORK, NY / ACCESSWIRE /July 30, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Mazor Robotics Ltd. ("Mazor" or the "Company") (NASDAQ: MZOR) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 17-cv-04422, is on behalf of a class consisting of investors who purchased or otherwise acquired Mazor's American Depositary Receipts ("ADRs") securities, seeking to recover compensable damages caused by Defendants' violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Mazor securities between November 8, 2016, and June 7, 2017, both dates inclusive, you have until August 8, 2017, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click here to join this class action]

Mazor is a medical device company that purportedly develops and markets innovative surgical guidance systems and complementary products. The Company claims that its expertise is computerized and imaging-based systems, primarily in the field of spine surgery, and that its Surgical Guidance Systems enable surgeons to advance from freehand surgical procedures to accurate, pre-planned, state-of-the-art, precision guided procedures.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) that the Company was engaged in conduct that subjected it to ISA investigation; (ii) that, as such the Company was exposed to potential liability; and (iii) as a result of the foregoing, Mazor's public statements were materially false and misleading at all relevant times.

On June 8, 2017, Mazor disclosed to investors that the Israel Securities Authority ("ISA") had conducted a search at the Company's offices in May 2017, and questioned certain of Mazor's officers in connection with an ISA investigation.

On this news, Mazor's ADR price fell $3.70, or 9.9%, to close at $33.67 on June 8, 2017. The next day, the ADR price continued to decline, falling another $3.08, or 9.1%, to close at $30.59 on June 9, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

SOURCE: Pomerantz LLP


ę Accesswire 2017
All news about MAZOR ROBOTICS LTD
2018Mazor Robotics : Shareholders Approve Merger Agreement With Medtronic
PU
2018Mazor Robotics : Reports Third Quarter and Nine Month 2018 Results
PU
2018Medtronic to acquire Mazor in $1.64 billion deal
RE
2018Mazor Robotics : Reports Second Quarter and First Half 2018 Results; Robotic Guidance Syst..
PR
2018Mazor Robotics : rsquo; Renaissance System installed at Georgia ASC
PU
2018Mazor Robotics : Reports Record First Quarter Results
PR
2018Mazor Robotics : to Report First Quarter Financial Results on May 14, 2018
PU
2018Mazor Robotics : to Present at the Barclays Global Healthcare Conference
PR
2018Mazor Robotics : Reports Record Fourth Quarter & Full Year 2017 Financial Results
PR
2018Mazor Robotics : Spine Surgeon in Spain Successfully Completes Europe's First Mazor Roboti..
PU
More news
Managers and Directors
Ori Hadomi Chief Executive Officer
Eliyahu Zehavi Chief Advanced Technology Officer
Doron Tavlin Vice President-Business Development
Dennis Devito Member-Medical Advisory Board
Meir Liebergall Member-Medical Advisory Board
Sector and Competitors
1st jan.Capi. (M$)
MAZOR ROBOTICS LTD0.00%0
THERMO FISHER SCIENTIFIC-14.88%219 934
DANAHER CORPORATION-18.47%195 269
INTUITIVE SURGICAL, INC.-24.29%94 693
BOSTON SCIENTIFIC CORPORATION7.42%65 356
SIEMENS HEALTHINEERS AG-24.89%57 925